Metraipolis › archive › dc_4f3fc50fd116

Artificial Intelligence-Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III,… — Europe PMC PMID:40859961

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40859961
DOI
10.1002/mco2.70324
License (as archived)
solo-consultazione
Archived
2026-11-10T09:41:26.104Z
SHA-256 of the archived text
f8d4f40a1d49c36160053c98b4e705d01068390e8e63b56bdd33aa43c50f6c4c
Stable URL of this page
https://metraipolis.com/documento/dc_4f3fc50fd116

How to cite

Artificial Intelligence-Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III,… — Europe PMC PMID:40859961 — Europe PMC (en), https://europepmc.org/article/MED/40859961 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4f3fc50fd116 (Metraipolis archive dc_4f3fc50fd116, sha256 f8d4f40a1d49c36160053c98b4e705d01068390e8e63b56bdd33aa43c50f6c4c)
BibTeX
@misc{dc4f3fc50fd116,
  title = {Artificial Intelligence-Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III,… — Europe PMC PMID:40859961},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40859961},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4f3fc50fd116; sha256 f8d4f40a1d49c36160053c98b4e705d01068390e8e63b56bdd33aa43c50f6c4c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40859961. Agents can read the archived copy with the MCP tool read_document.